Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aopeng Medical is a Shanghai-based medtech company developing robotic systems for endovascular interventional surgery. Its lead platform, ALLVAS, is an endovascular intervention surgical robot designed to support minimally invasive vascular procedures including aortic, peripheral, coronary, neurovascular, and vascular tumor interventions. The company has reported first-in-human clinical use of its system in thoracic and abdominal aortic aneurysm repair and in iliac artery intervention, and it is advancing toward mass production and commercialization. Aopeng Medical combines robotics, artificial intelligence, software, and image-guided intervention technologies to reduce radiation exposure, improve procedural precision, and enable more intelligent catheter-based surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aopeng Medical.